CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
- Type
- Retraction
- Notice date
- 9/29/2025 0:00
- Journal
- Nanoscale Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Notice DOI
- 10.1039/d5na90068a
- Original paper DOI
- 10.1039/d0na00758g
Reasons
- Concerns/Issues about Data
- Duplication of/in Image
- Falsification/Fabrication of Data
- Falsification/Fabrication of Image
- Investigation by Company/Institution
- Objections by Author(s)
- Unreliable Data
- Upgrade/Update of Prior Notice(s)